Net Income

In a bid to bolster US energy security, Eagle Nuclear hires SLR to navigate permitting for its Aurora project, aiming for FAST-41 status.

With fresh funding secured, Dogwood Therapeutics pushes its promising nerve pain drug, Halneuron®, toward a pivotal data readout later this year.

A triple win from Black Book Research for IKS Health isn't just a trophy; it's proof that AI is now the backbone of modern healthcare revenue and operations.

With a major Series B financing, Crossbow advances its TCR-mimetic therapies, aiming to unlock a new frontier in the fight against a broad range of cancers.

Dr. Toyin Ajayi's board appointment signals a major strategic move to integrate nutrition into healthcare for America's most vulnerable populations.

Reliance Jio and Good Game launch a massive reality show with a ₹1 crore prize, blending esports and entertainment to find India's first global gaming icon.

The rapidly growing clean wine brand Avaline is placing new sales leaders in key cities, signaling an aggressive push for national market dominance.

JenaValve's Trilogy system gains historic FDA approval, offering a new, minimally invasive option for high-risk patients with a life-threatening heart condition.

FHFA's approval of VantageScore is igniting fierce competition, promising nearly $1B in savings and opening new paths to homeownership for millions.

Cingulate Inc. faces a critical FDA decision for its novel ADHD drug, but manufacturing queries and a tight cash runway create a high-stakes countdown.

Private equity firm Manna Tree hires Jennifer Roach as Managing Director, signaling a major play to dominate the booming consumer health and wellness market.

A new partnership merges cybersecurity and HR compliance, signaling a shift toward integrated, behavior-focused training to build more resilient work cultures.

A new US-Canadian partnership between UNION and NALAGX aims to use software-driven factories to solve the critical 155mm artillery shell shortage.

With its 20th straight #1 G2 award, FinQuery solidifies its leadership and signals a broader shift from manual tasks to AI-powered intelligent accounting.

Artelo Biosciences is testing a novel cannabinoid drug for glaucoma, aiming to protect vision in a way current treatments can't—all without diluting shares.

A landmark deal between Australia's VVMF and UK's OXB aims to create a new cell and gene therapy manufacturing hub for the booming Asia-Pacific market.

A new book by a neurologist, attorney, and MBA argues that five powerful systems are contributing to a crisis in children's neurodevelopment.

The AI cloud firm's upsized $4.0 billion convertible note offering signals strong investor confidence as it races to build out data centers for mega-clients.

New research shows AI tools are failing to curb alert fatigue, leaving enterprises exposed and raising new concerns about third-party data risks.

Operator of China's BOSS Zhipin announces a major dividend and buyback plan, signaling deep confidence in its market dominance and future profitability.